These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 32382832)

  • 21. Iron Oxide Nanoparticles as T
    Jeon M; Halbert MV; Stephen ZR; Zhang M
    Adv Mater; 2021 Jun; 33(23):e1906539. PubMed ID: 32495404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation, characterization, and evaluation of amino acid modified magnetic nanoparticles: drug delivery and MRI contrast agent applications.
    Nosrati H; Salehiabar M; Bagheri Z; Rashidzadeh H; Davaran S; Danafar H
    Pharm Dev Technol; 2018 Dec; 23(10):1156-1167. PubMed ID: 30320535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smart Design of ZnFe and ZnFe@Fe Nanoparticles for MRI-Tracked Magnetic Hyperthermia Therapy: Challenging Classical Theories of Nanoparticles Growth and Nanomagnetism.
    Caro C; Guzzi C; Moral-Sánchez I; Urbano-Gámez JD; Beltrán AM; García-Martín ML
    Adv Healthc Mater; 2024 May; 13(12):e2304044. PubMed ID: 38303644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paramagnetic nanoparticle T1 and T2 MRI contrast agents.
    Xu W; Kattel K; Park JY; Chang Y; Kim TJ; Lee GH
    Phys Chem Chem Phys; 2012 Oct; 14(37):12687-700. PubMed ID: 22885983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
    Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
    Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
    [No Abstract]   [Full Text] [Related]  

  • 26. Screen-based analysis of magnetic nanoparticle libraries formed using peptidic iron oxide ligands.
    Barch M; Okada S; Bartelle BB; Jasanoff A
    J Am Chem Soc; 2014 Sep; 136(36):12516-9. PubMed ID: 25158100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron oxide nanoparticles stabilized with dendritic polyglycerols as selective MRI contrast agents.
    Nordmeyer D; Stumpf P; Gröger D; Hofmann A; Enders S; Riese SB; Dernedde J; Taupitz M; Rauch U; Haag R; Rühl E; Graf C
    Nanoscale; 2014 Aug; 6(16):9646-54. PubMed ID: 24991655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic nanoparticles as contrast agents in biomedical imaging: recent advances in iron- and manganese-based magnetic nanoparticles.
    Felton C; Karmakar A; Gartia Y; Ramidi P; Biris AS; Ghosh A
    Drug Metab Rev; 2014 May; 46(2):142-54. PubMed ID: 24754519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving detection specificity of iron oxide nanoparticles (IONPs) using the SWIFT sequence with long T(2) suppression.
    Wang L; Tang W; Zhen Z; Chen H; Xie J; Zhao Q
    Magn Reson Imaging; 2014 Jul; 32(6):671-8. PubMed ID: 24666573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An update on clinical applications of magnetic nanoparticles for increasing the resolution of magnetic resonance imaging.
    Zeinali Sehrig F; Majidi S; Asvadi S; Hsanzadeh A; Rasta SH; Emamverdy M; Akbarzadeh J; Jahangiri S; Farahkhiz S; Akbarzadeh A
    Artif Cells Nanomed Biotechnol; 2016 Nov; 44(7):1583-8. PubMed ID: 26584684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrashort echo time (UTE) imaging of receptor targeted magnetic iron oxide nanoparticles in mouse tumor models.
    Wang L; Zhong X; Qian W; Huang J; Cao Z; Yu Q; Lipowska M; Lin R; Wang A; Yang L; Mao H
    J Magn Reson Imaging; 2014 Nov; 40(5):1071-81. PubMed ID: 25485347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
    Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
    ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Choose your cell model wisely: The in vitro nanoneurotoxicity of differentially coated iron oxide nanoparticles for neural cell labeling.
    Joris F; Valdepérez D; Pelaz B; Wang T; Doak SH; Manshian BB; Soenen SJ; Parak WJ; De Smedt SC; Raemdonck K
    Acta Biomater; 2017 Jun; 55():204-213. PubMed ID: 28373085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analyzing the mechanisms of iron oxide nanoparticles interactions with cells: A road from failure to success in clinical applications.
    Frtús A; Smolková B; Uzhytchak M; Lunova M; Jirsa M; Kubinová Š; Dejneka A; Lunov O
    J Control Release; 2020 Dec; 328():59-77. PubMed ID: 32860925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro MRI of biodegradable hybrid (iron oxide/polycaprolactone) magnetic nanoparticles prepared via modified double emulsion evaporation mechanism.
    Ahmed N; Ahmad NM; Fessi H; Elaissari A
    Colloids Surf B Biointerfaces; 2015 Jun; 130():264-71. PubMed ID: 25960142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic targeting combined with active targeting of dual-ligand iron oxide nanoprobes to promote the penetration depth in tumors for effective magnetic resonance imaging and hyperthermia.
    Chen L; Wu Y; Wu H; Li J; Xie J; Zang F; Ma M; Gu N; Zhang Y
    Acta Biomater; 2019 Sep; 96():491-504. PubMed ID: 31302299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bevacizumab and near infrared probe conjugated iron oxide nanoparticles for vascular endothelial growth factor targeted MR and optical imaging.
    Lin R; Huang J; Wang L; Li Y; Lipowska M; Wu H; Yang J; Mao H
    Biomater Sci; 2018 May; 6(6):1517-1525. PubMed ID: 29652061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancreatic cancer.
    Zou J; Chen S; Li Y; Zeng L; Lian G; Li J; Chen S; Huang K; Chen Y
    Nanoscale; 2020 Feb; 12(7):4473-4490. PubMed ID: 32031201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting Pancreatic Cancer Cells with Peptide-Functionalized Polymeric Magnetic Nanoparticles.
    Zhu X; Lu N; Zhou Y; Xuan S; Zhang J; Giampieri F; Zhang Y; Yang F; Yu R; Battino M; Wang Z
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31248076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iron oxide nanoparticles for immune cell labeling and cancer immunotherapy.
    Chung S; Revia RA; Zhang M
    Nanoscale Horiz; 2021 Sep; 6(9):696-717. PubMed ID: 34286791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.